Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
Top Cited Papers
Open Access
- 19 March 2012
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 12 (5), 1157-1167
- https://doi.org/10.1111/j.1600-6143.2012.04013.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- De Novo Donor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft FailureAmerican Journal of Transplantation, 2009
- Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal AllograftsTransplantation, 2009
- Reducing De Novo Donor-Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft LossAmerican Journal of Transplantation, 2009
- Poor graft outcome in recipients withde novodonor-specific anti-HLA antibodies after living related kidney transplantationTransplant International, 2008
- Post-Transplant Anti-HLA Class II Antibodies as Risk Factor for Late Kidney Allograft FailureAmerican Journal of Transplantation, 2006
- Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney TransplantationJournal of the American Society of Nephrology, 2005
- Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantationTransplant International, 2005
- Predicting Kidney Graft Failure by HLA Antibodies: a Prospective TrialAmerican Journal of Transplantation, 2004
- Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1Transplantation, 2003
- POSTTRANSPLANT ANTIDONOR LYMPHOCYTOTOXIC ANTIBODY PRODUCTION IN RELATION TO GRAFT OUTCOMETransplantation, 1987